300858 科拓生物
已收盘 04-24 15:00:00
资讯
新帖
简况
4月24日科拓生物跌8.34%,工银消费服务混合A基金重仓该股
证券之星 · 04-24 16:37
4月24日科拓生物跌8.34%,工银消费服务混合A基金重仓该股
科拓生物(300858)3月31日股东户数1.97万户,较上期增加20.15%
证券之星 · 04-22
科拓生物(300858)3月31日股东户数1.97万户,较上期增加20.15%
图解科拓生物一季报:第一季度单季净利润同比下降26.46%
证券之星 · 04-22
图解科拓生物一季报:第一季度单季净利润同比下降26.46%
科拓生物最新公告:拟1亿-1.5亿元回购股份
证券之星 · 04-21
科拓生物最新公告:拟1亿-1.5亿元回购股份
科拓生物(300858.SZ)发布一季度业绩,归母净利润1495.13万元,下降26.46%
智通财经 · 04-21
科拓生物(300858.SZ)发布一季度业绩,归母净利润1495.13万元,下降26.46%
4月20日科拓生物跌8.68%,浙商科创一个月滚动持有混合A基金重仓该股
证券之星 · 04-20
4月20日科拓生物跌8.68%,浙商科创一个月滚动持有混合A基金重仓该股
4月17日科拓生物涨8.30%,浙商科创一个月滚动持有混合A基金重仓该股
证券之星 · 04-17
4月17日科拓生物涨8.30%,浙商科创一个月滚动持有混合A基金重仓该股
4月16日科拓生物涨10.17%,工银消费服务混合A基金重仓该股
证券之星 · 04-16
4月16日科拓生物涨10.17%,工银消费服务混合A基金重仓该股
4月14日科拓生物涨12.88%,工银消费服务混合A基金重仓该股
证券之星 · 04-14
4月14日科拓生物涨12.88%,工银消费服务混合A基金重仓该股
科拓生物:公司已与多家国内头部乳制品企业建立长期稳定合作
证券之星 · 03-30
科拓生物:公司已与多家国内头部乳制品企业建立长期稳定合作
3月27日科拓生物(300858)龙虎榜数据:机构净卖出1418.49万元
证券之星 · 03-27
3月27日科拓生物(300858)龙虎榜数据:机构净卖出1418.49万元
3月27日科拓生物涨19.99%,工银消费服务混合A基金重仓该股
证券之星 · 03-27
3月27日科拓生物涨19.99%,工银消费服务混合A基金重仓该股
1月19日科拓生物发布公告,股东减持103.95万股
证券之星 · 01-19
1月19日科拓生物发布公告,股东减持103.95万股
科拓生物(300858)披露向特定对象发行股票解除限售上市流通提示性公告,1月15日股价下跌1.46%
证券之星 · 01-15
科拓生物(300858)披露向特定对象发行股票解除限售上市流通提示性公告,1月15日股价下跌1.46%
科拓生物(300858)披露持股5%以上股东、特定股东股份减持计划实施完毕公告,12月29日股价上涨0.66%
证券之星 · 2025-12-29
科拓生物(300858)披露持股5%以上股东、特定股东股份减持计划实施完毕公告,12月29日股价上涨0.66%
12月26日科拓生物发布公告,股东减持505.67万股
证券之星 · 2025-12-26
12月26日科拓生物发布公告,股东减持505.67万股
股市必读:12月25日科拓生物现1笔折价14.99%的大宗交易 合计成交202.66万元
证券之星 · 2025-12-26
股市必读:12月25日科拓生物现1笔折价14.99%的大宗交易 合计成交202.66万元
12月24日科拓生物现1笔折价14.98%的大宗交易 合计成交500.5万元
证券之星 · 2025-12-24
12月24日科拓生物现1笔折价14.98%的大宗交易 合计成交500.5万元
科拓生物:打破国外菌株技术和产品垄断
证券之星 · 2025-12-24
科拓生物:打破国外菌株技术和产品垄断
科拓生物:目前公司暂无在海南投资发展的计划
证券之星 · 2025-12-24
科拓生物:目前公司暂无在海南投资发展的计划
加载更多
公司概况
公司名称:
北京科拓恒通生物技术股份有限公司
所属行业:
食品制造业
上市日期:
2020-07-27
主营业务:
北京科拓恒通生物技术股份有限公司的主营业务是食用益生菌制品、动植物微生态制剂以及复配食品添加剂研发、生产与销售。公司的主要产品是食用益生菌制品、动植物微生态制剂、复配食品添加剂。公司是国家高新技术企业、北京市知识产权优势单位、北京市企业技术中心、专精特新中小企业,项目荣获2023年度国家科学技术进步奖二等奖,2024年度内蒙古自治区科学技术进步奖一等奖。
发行价格:
23.70
{"stockData":{"symbol":"300858","market":"SZ","secType":"STK","nameCN":"科拓生物","latestPrice":21.22,"timestamp":1777014213000,"preClose":23.15,"halted":0,"volume":37857060,"delay":0,"changeRate":-0.0834,"floatShares":196000000,"shares":263000000,"eps":0.3384,"marketStatus":"已收盘","change":-1.93,"latestTime":"04-24 15:00:00","open":23.64,"high":23.99,"low":21.15,"amount":842000000,"amplitude":0.1227,"askPrice":21.23,"askSize":26,"bidPrice":21.22,"bidSize":16,"shortable":0,"etf":0,"ttmEps":0.3384,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1777253400000},"marketStatusCode":5,"adr":0,"adjPreClose":23.15,"symbolType":"stock","openAndCloseTimeList":[[1776994200000,1777001400000],[1777006800000,1777014000000]],"highLimit":25.47,"lowLimit":20.84,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":263495118,"isCdr":false,"pbRate":3.28,"roa":"--","peRate":62.706856,"roe":"0.81%","epsLYR":0.36,"committee":0.291572,"marketValue":5591000000,"turnoverRate":0.1934,"status":1,"floatMarketCap":4154000000},"requestUrl":"/m/hq/s/300858","defaultTab":"news","newsList":[{"id":"2629160798","title":"4月24日科拓生物跌8.34%,工银消费服务混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2629160798","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629160798?lang=zh_cn&edition=full","pubTime":"2026-04-24 16:37","pubTimestamp":1777019837,"startTime":"0","endTime":"0","summary":"证券之星消息,4月24日科拓生物跌8.34%,收盘报21.22元,换手率19.34%,成交量37.86万手,成交额8.42亿元。重仓科拓生物的公募基金请见下表:根据2026基金Q1季报公募基金重仓股数据,重仓该股的公募基金共3家,其中持有数量最多的公募基金为工银瑞信基金的工银消费服务混合A。该公募基金现任基金经理为林梦。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042400050526.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300858","000806.SH","BK0226"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629011157","title":"科拓生物(300858)3月31日股东户数1.97万户,较上期增加20.15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2629011157","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629011157?lang=zh_cn&edition=full","pubTime":"2026-04-22 17:33","pubTimestamp":1776850396,"startTime":"0","endTime":"0","summary":"证券之星消息,近日科拓生物披露,截至2026年3月31日公司股东户数为1.97万户,较12月31日增加3302.0户,增幅为20.15%。在化学制品行业个股中,科拓生物股东户数低于行业平均水平,截至3月31日,化学制品行业平均股东户数为2.77万户。根据统计,科拓生物2025年12月31日至2026年3月31日,主力资金净流入7250.85万元,游资资金净流入3730.21万元,散户资金净流出1.1亿元。期间龙虎榜该股共上榜1次,机构专用席位上榜1次。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042200040946.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0226","300858"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629009059","title":"图解科拓生物一季报:第一季度单季净利润同比下降26.46%","url":"https://stock-news.laohu8.com/highlight/detail?id=2629009059","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629009059?lang=zh_cn&edition=full","pubTime":"2026-04-22 01:29","pubTimestamp":1776792545,"startTime":"0","endTime":"0","summary":"证券之星消息,科拓生物2026年一季报显示,一季度公司主营收入8499.59万元,同比上升9.51%;归母净利润1495.13万元,同比下降26.46%;扣非净利润1246.18万元,同比下降25.22%;负债率8.36%,投资收益208.61万元,财务费用-367.04万元,毛利率45.41%。财报数据概要请见下图:以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042200003726.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300858"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629031703","title":"科拓生物最新公告:拟1亿-1.5亿元回购股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2629031703","media":"证券之星","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629031703?lang=zh_cn&edition=full","pubTime":"2026-04-21 20:49","pubTimestamp":1776775778,"startTime":"0","endTime":"0","summary":"科拓生物(300858.SZ)公告称,公司拟使用自有资金以集中竞价交易方式回购部分社会公众股份。本次回购资金总额不低于1亿元(含),不超过1.5亿元(含);回购价格不超过29.46元/股(含)。回购股份将用于实施股权激励或员工持股计划。以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042100049967.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0226","300858"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629031161","title":"科拓生物(300858.SZ)发布一季度业绩,归母净利润1495.13万元,下降26.46%","url":"https://stock-news.laohu8.com/highlight/detail?id=2629031161","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629031161?lang=zh_cn&edition=full","pubTime":"2026-04-21 20:45","pubTimestamp":1776775552,"startTime":"0","endTime":"0","summary":"智通财经APP讯,科拓生物(300858.SZ)发布2026年第一季度报告,该公司营业收入为8499.59万元,同比增长9.51%。归属于上市公司股东的净利润为1495.13万元,同比减少26.46%。归属于上市公司股东的扣除非经常性损益的净利润为1246.18万元,同比减少25.22%。基本每股收益为0.06元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1431524.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["300858"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628811743","title":"4月20日科拓生物跌8.68%,浙商科创一个月滚动持有混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2628811743","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2628811743?lang=zh_cn&edition=full","pubTime":"2026-04-20 16:23","pubTimestamp":1776673380,"startTime":"0","endTime":"0","summary":"证券之星消息,4月20日科拓生物跌8.68%,收盘报23.24元,换手率17.63%,成交量34.51万手,成交额8.12亿元。重仓科拓生物的公募基金请见下表:根据2026基金Q1季报公募基金重仓股数据,重仓该股的公募基金共1家,其中持有数量最多的公募基金为浙商基金的浙商科创一个月滚动持有混合A。浙商科创一个月滚动持有混合A目前规模为0.31亿元,最新净值1.5858,较上一交易日上涨0.42%,近一年上涨39.66%。该公募基金现任基金经理为成子浩 佘江科。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042000021516.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300858","159982","BK0226"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628795582","title":"4月17日科拓生物涨8.30%,浙商科创一个月滚动持有混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2628795582","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2628795582?lang=zh_cn&edition=full","pubTime":"2026-04-17 16:21","pubTimestamp":1776414079,"startTime":"0","endTime":"0","summary":"证券之星消息,4月17日科拓生物涨8.30%创60日新高,收盘报25.45元,换手率22.45%,成交量43.94万手,成交额11.23亿元。重仓科拓生物的公募基金请见下表:根据2026基金Q1季报公募基金重仓股数据,重仓该股的公募基金共1家,其中持有数量最多的公募基金为浙商基金的浙商科创一个月滚动持有混合A。浙商科创一个月滚动持有混合A目前规模为0.38亿元,最新净值1.5791,较上一交易日上涨1.41%,近一年上涨39.66%。该公募基金现任基金经理为成子浩 佘江科。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026041700030115.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["159982","BK0226","300858"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627983672","title":"4月16日科拓生物涨10.17%,工银消费服务混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2627983672","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2627983672?lang=zh_cn&edition=full","pubTime":"2026-04-16 16:21","pubTimestamp":1776327674,"startTime":"0","endTime":"0","summary":"证券之星消息,4月16日科拓生物涨10.17%,收盘报23.5元,换手率20.44%,成交量40.01万手,成交额8.72亿元。重仓科拓生物的公募基金请见下表:根据2025基金年报公募基金重仓股数据,重仓该股的公募基金共4家,其中持有数量最多的公募基金为工银瑞信基金的工银消费服务混合A。该公募基金现任基金经理为林梦。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026041600028405.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300858","BK0226","000806.SH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627416514","title":"4月14日科拓生物涨12.88%,工银消费服务混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2627416514","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2627416514?lang=zh_cn&edition=full","pubTime":"2026-04-14 16:16","pubTimestamp":1776154615,"startTime":"0","endTime":"0","summary":"证券之星消息,4月14日科拓生物涨12.88%创60日新高,收盘报21.3元,换手率14.02%,成交量27.45万手,成交额5.43亿元。重仓科拓生物的公募基金请见下表:根据2025基金年报公募基金重仓股数据,重仓该股的公募基金共4家,其中持有数量最多的公募基金为工银瑞信基金的工银消费服务混合A。该公募基金现任基金经理为林梦。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026041400025404.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000806.SH","BK0226","300858"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623239029","title":"科拓生物:公司已与多家国内头部乳制品企业建立长期稳定合作","url":"https://stock-news.laohu8.com/highlight/detail?id=2623239029","media":"证券之星","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2623239029?lang=zh_cn&edition=full","pubTime":"2026-03-30 16:51","pubTimestamp":1774860666,"startTime":"0","endTime":"0","summary":"证券之星消息,科拓生物(300858)03月30日在投资者关系平台上答复投资者关心的问题。投资者提问:董秘好!国内头部的益生菌乳酸发酵奶制品的公司是否都是贵公司的核心客户?公司产品是否出口?出口比例是多少?科拓生物回复:尊敬的投资者您好,公司已与多家国内头部乳制品企业建立长期稳定合作,产品已有海外销售,目前整体外销占比较低,感谢您的关注。以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026033000022214.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0226","300858"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622584497","title":"3月27日科拓生物(300858)龙虎榜数据:机构净卖出1418.49万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2622584497","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2622584497?lang=zh_cn&edition=full","pubTime":"2026-03-27 17:17","pubTimestamp":1774603050,"startTime":"0","endTime":"0","summary":"证券之星消息,沪深交易所2026年3月27日公布的交易公开信息显示,科拓生物因日涨幅达到15%的前5只证券登上龙虎榜。此次是近5个交易日内第1次上榜。截至2026年3月27日收盘,科拓生物报收于18.19元,上涨19.99%,换手率7.81%,成交量15.29万手,成交额2.64亿元。从龙虎榜公布的当日买卖数据来看,机构合计净卖出1418.49万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032700036004.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0226","300858"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622493598","title":"3月27日科拓生物涨19.99%,工银消费服务混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2622493598","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2622493598?lang=zh_cn&edition=full","pubTime":"2026-03-27 16:18","pubTimestamp":1774599489,"startTime":"0","endTime":"0","summary":"证券之星消息,3月27日科拓生物涨19.99%,收盘报18.19元,换手率7.81%,成交量15.29万手,成交额2.64亿元。重仓科拓生物的公募基金请见下表:根据2025基金年报公募基金重仓股数据,重仓该股的公募基金共4家,其中持有数量最多的公募基金为工银瑞信基金的工银消费服务混合A。工银消费服务混合A目前规模为1.78亿元,最新净值2.348,较上一交易日下跌1.39%,近一年下跌5.29%。该公募基金现任基金经理为林梦。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032700033490.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000806.SH","BK0226","300858"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2604180471","title":"1月19日科拓生物发布公告,股东减持103.95万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2604180471","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2604180471?lang=zh_cn&edition=full","pubTime":"2026-01-19 19:01","pubTimestamp":1768820479,"startTime":"0","endTime":"0","summary":"证券之星消息,1月19日科拓生物发布公告《科拓生物:关于特定股东减持计划期限届满的公告》,其股东张列兵于2025年10月19日至2026年1月15日间合计减持103.95万股,占公司目前总股本的0.3945%,变动期间该股股价上涨6.02%,截止1月15日收盘报17.61元。股东增减持详情见下表:根据科拓生物2025年三季报公布的十大股东详情如下:以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011900028619.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0226","300858"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2603035236","title":"科拓生物(300858)披露向特定对象发行股票解除限售上市流通提示性公告,1月15日股价下跌1.46%","url":"https://stock-news.laohu8.com/highlight/detail?id=2603035236","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603035236?lang=zh_cn&edition=full","pubTime":"2026-01-15 17:36","pubTimestamp":1768469781,"startTime":"0","endTime":"0","summary":"截至2026年1月15日收盘,科拓生物报收于17.61元,较前一交易日下跌1.46%,最新总市值为46.4亿元。该股当日开盘17.95元,最高18.0元,最低17.43元,成交额达9937.42万元,换手率为2.88%。公告显示,本次解除限售的股份为控股股东、实际控制人孙天松认购的向特定对象发行的股份,解除限售数量为2,005,349股,占公司总股本0.76%。本次解除限售股份的上市流通日期为2026年1月19日。公司总股本为263,495,118股,有限售条件股份占比25.71%。保荐机构对本次解除限售无异议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011500029085.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0226","300858"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2595786204","title":"科拓生物(300858)披露持股5%以上股东、特定股东股份减持计划实施完毕公告,12月29日股价上涨0.66%","url":"https://stock-news.laohu8.com/highlight/detail?id=2595786204","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2595786204?lang=zh_cn&edition=full","pubTime":"2025-12-29 17:46","pubTimestamp":1767001575,"startTime":"0","endTime":"0","summary":"截至2025年12月29日收盘,科拓生物报收于16.87元,较前一交易日上涨0.66%,最新总市值为44.45亿元。公司近日发布公告称,持股5%以上股东宁波顺懿创业投资合伙企业及特定股东宁波科汇达创业投资合伙企业股份减持计划已实施完毕。宁波顺懿通过集中竞价和大宗交易减持合计7,904,000股,减持比例1.9998%,持股比例由9.0802%降至6.0806%;宁波科汇达通过集中竞价减持2,634,000股,减持比例0.9996%,持股比例由3.2717%降至2.2721%。本次减持未违反相关承诺及规定,不影响公司控制权。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025122900024475.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300858","BK0226"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2594634299","title":"12月26日科拓生物发布公告,股东减持505.67万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2594634299","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2594634299?lang=zh_cn&edition=full","pubTime":"2025-12-26 21:01","pubTimestamp":1766754109,"startTime":"0","endTime":"0","summary":"证券之星消息,12月26日科拓生物发布公告《科拓生物:关于持股5%以上股东、特定股东股份减持计划实施完毕的公告》,其股东宁波顺懿创业投资合伙企业(有限合伙)、宁波科汇达创业投资合伙企业(有限合伙)于2025年11月24日至2025年12月25日间合计减持505.67万股,占公司目前总股本的1.919%,变动期间该股股价下跌5.61%,截止12月25日收盘报17.15元。股东增减持详情见下表:根据科拓生物2025年三季报公布的十大股东详情如下:以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025122600033629.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300858","BK0226"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2594256402","title":"股市必读:12月25日科拓生物现1笔折价14.99%的大宗交易 合计成交202.66万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2594256402","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2594256402?lang=zh_cn&edition=full","pubTime":"2025-12-26 04:12","pubTimestamp":1766693535,"startTime":"0","endTime":"0","summary":"截至2025年12月25日收盘,科拓生物报收于17.15元,上涨1.96%,换手率2.1%,成交量4.07万手,成交额6933.41万元。交易信息汇总资金流向12月25日主力资金净流入211.37万元;游资资金净流入410.04万元;散户资金净流出621.41万元。大宗交易12月25日科拓生物发生1笔折价14.99%的大宗交易,合计成交202.66万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025122600001312.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0226","300858"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2593475814","title":"12月24日科拓生物现1笔折价14.98%的大宗交易 合计成交500.5万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2593475814","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593475814?lang=zh_cn&edition=full","pubTime":"2025-12-24 17:45","pubTimestamp":1766569507,"startTime":"0","endTime":"0","summary":"近三个月该股共发生6笔大宗交易,合计成交5.13万手,折价成交6笔。该股近期无解禁股上市。截至2025年12月24日收盘,科拓生物报收于16.82元,上涨1.08%,换手率1.4%,成交量2.72万手,成交额4550.37万元。该股近半年内有股东持股变动,合计净减持284.64万股,股东增减持明细如下表:该股最近90天内共有2家机构给出评级,买入评级2家。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025122400028673.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300858","BK0226"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2593742302","title":"科拓生物:打破国外菌株技术和产品垄断","url":"https://stock-news.laohu8.com/highlight/detail?id=2593742302","media":"证券之星","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593742302?lang=zh_cn&edition=full","pubTime":"2025-12-24 11:37","pubTimestamp":1766547422,"startTime":"0","endTime":"0","summary":"证券之星消息,科拓生物(300858)12月23日在投资者关系平台上答复投资者关心的问题。投资者提问:请问公司益生菌国产替代情况如何?科拓生物回复:尊敬的投资者您好,依托在益生菌领域的技术积累与创新成果,公司打破了国外菌株、技术和产品的垄断。同时,凭借从研发到生产的全产业链自主能力,确保了供应链的安全与稳定。这使得公司的产品在性价比与定制化服务上极具竞争力,并持续获得市场与客户的广泛认可,推动市场份额稳步提升。感谢您的关注!以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025122400014640.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0226","300858"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2593033423","title":"科拓生物:目前公司暂无在海南投资发展的计划","url":"https://stock-news.laohu8.com/highlight/detail?id=2593033423","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593033423?lang=zh_cn&edition=full","pubTime":"2025-12-24 11:36","pubTimestamp":1766547410,"startTime":"0","endTime":"0","summary":"证券之星消息,科拓生物(300858)12月23日在投资者关系平台上答复投资者关心的问题。投资者提问:请问公司有在海南投资发展的计划吗科拓生物回复:尊敬的投资者您好,目前公司暂无该计划,感谢您的关注!以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025122400014618.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0226","300858"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1777162891263,"stockEarnings":[{"period":"1week","weight":-0.1662},{"period":"1month","weight":0.3806},{"period":"3month","weight":0.1577},{"period":"6month","weight":0.246},{"period":"1year","weight":0.338},{"period":"ytd","weight":0.2654}],"compareEarnings":[{"period":"1week","weight":0.007},{"period":"1month","weight":0.0377},{"period":"3month","weight":-0.0136},{"period":"6month","weight":0.0328},{"period":"1year","weight":0.2374},{"period":"ytd","weight":0.028}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"北京科拓恒通生物技术股份有限公司","boardCode":"AI0014","boardName":"食品制造业","stockholders":"19692人(较上一季度增加20.15%)","perCapita":"9940股","listingDate":"2020-07-27","address":"北京市怀柔区雁栖经济开发区牤牛河路31号院1号-2","registeredCapital":"26349万元","survey":" 北京科拓恒通生物技术股份有限公司的主营业务是食用益生菌制品、动植物微生态制剂以及复配食品添加剂研发、生产与销售。公司的主要产品是食用益生菌制品、动植物微生态制剂、复配食品添加剂。公司是国家高新技术企业、北京市知识产权优势单位、北京市企业技术中心、专精特新中小企业,项目荣获2023年度国家科学技术进步奖二等奖,2024年度内蒙古自治区科学技术进步奖一等奖。","listedPrice":23.7},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.0","shortVersion":"4.42.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"科拓生物(300858)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供科拓生物(300858)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"科拓生物,300858,科拓生物股票,科拓生物股票老虎,科拓生物股票老虎国际,科拓生物行情,科拓生物股票行情,科拓生物股价,科拓生物股市,科拓生物股票价格,科拓生物股票交易,科拓生物股票购买,科拓生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"科拓生物(300858)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供科拓生物(300858)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}